{"originalText": "，患者约于3年前因“乙状结肠癌”于2014-02-19日在全麻上行乙状结肠部分切除、乙状结肠单腔造瘘，阑尾切除术。手术过程顺利，术后给予抗感染及营养支持治疗，患者恢复好。，术后病理：结肠腺癌(中低度分化),浸润溃疡型,面积2.2*1.2CM，侵达浆膜，少数脉管内查见癌栓。双端切线未查见癌。结肠肠壁部分坏死、穿孔，肠系膜及肠壁周围脂肪组织化脓、坏死。肠壁一站（3个）淋巴结未查见癌。慢性阑尾炎。，免疫组化染色示癌组织：ERCC1（+）、TS（+）。术后给予患者化疗4周期，，方案为：奥沙利铂200MG D1+亚叶酸钙0.3G D2-6 +替加氟1000MG D2-6 静滴，同时给与升白细胞、护肝、止吐、免疫增强治疗，患者化疗过程平稳。后患者拒绝继续化疗，未规律复查。院外期间，患者无发热，无腹痛腹胀不适，大便通畅。现患者为行复查来我科就诊，以“乙状结肠癌术后、乙状结肠造瘘术后”收入院。   病人自下次出院以来，神志清，精神可，饮食可，大、小便正常，体重未见明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 10, "end_pos": 15}, {"label_type": "手术", "overlap": 0, "start_pos": 33, "end_pos": 56}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 91, "end_pos": 102}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 145, "end_pos": 147}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 147, "end_pos": 148}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 157, "end_pos": 158}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 161, "end_pos": 162}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 175, "end_pos": 186}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 191, "end_pos": 196}, {"end_pos": 245, "label_type": "药物", "overlap": 0, "start_pos": 241}, {"end_pos": 258, "label_type": "药物", "overlap": 0, "start_pos": 254}, {"end_pos": 272, "label_type": "药物", "overlap": 0, "start_pos": 269}, {"end_pos": 298, "label_type": "解剖部位", "overlap": 0, "start_pos": 297}, {"end_pos": 347, "label_type": "解剖部位", "overlap": 0, "start_pos": 346}, {"end_pos": 349, "label_type": "解剖部位", "overlap": 0, "start_pos": 348}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 373, "end_pos": 380}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 381, "end_pos": 389}]}
